Your browser doesn't support javascript.
loading
Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-naïve residents of long-term care facilities who survive natural infection.
Tut, Gokhan; Lancaster, Tara; Butler, Megan S; Sylla, Panagiota; Spalkova, Eliska; Bone, David; Kaur, Nayandeep; Bentley, Christopher; Amin, Umayr; Jadir, Azar T; Hulme, Samuel; Ayodel, Morenike; Dowell, Alexander C; Pearce, Hayden; Zuo, Jianmin; Margielewska-Davies, Sandra; Verma, Kriti; Nicol, Samantha; Begum, Jusnara; Jinks, Elizabeth; Tut, Elif; Bruton, Rachel; Krutikov, Maria; Shrotri, Madhumita; Giddings, Rebecca; Azmi, Borscha; Fuller, Chris; Irwin-Singer, Aidan; Hayward, Andrew; Copas, Andrew; Shallcross, Laura; Moss, Paul.
Afiliação
  • Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. g.tut@bham.ac.uk.
  • Lancaster T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Butler MS; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Spalkova E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Kaur N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Amin U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Jadir AT; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Hulme S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Ayodel M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Dowell AC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Pearce H; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Zuo J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Margielewska-Davies S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Verma K; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Nicol S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Begum J; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Jinks E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Tut E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Krutikov M; UCL Institute of Health Informatics, London, UK.
  • Shrotri M; UCL Institute of Health Informatics, London, UK.
  • Giddings R; UCL Institute of Health Informatics, London, UK.
  • Azmi B; UCL Institute of Health Informatics, London, UK.
  • Fuller C; UCL Institute of Health Informatics, London, UK.
  • Irwin-Singer A; Department of Health and Social Care, London, UK.
  • Hayward A; Health Data Research UK, London, UK.
  • Copas A; UCL Institute for Global Health, London, UK.
  • Shallcross L; UCL Institute of Health Informatics, London, UK.
  • Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. p.moss@bham.ac.uk.
Nat Aging ; 2(6): 536-547, 2022 06.
Article em En | MEDLINE | ID: mdl-37118449
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 Tipo de estudo: Observational_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 Tipo de estudo: Observational_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article